The American Society of Medical Oncology (ASCO) has named a former IBM Watson government as the brand new CEO of its CancerLinQ large records platform.
Cory Wiegert used to be maximum lately vice chairman of product control for IBM Watson Well being. Previous to becoming a member of IBM, Wiegert held positions with Sterling Trade, Siebel Methods Inc., Centura Instrument and Protection-Kleen.
Kevin Fitzpatrick stepped down because the nonprofit CancerLinQ’s CEO in April 2018. Richard Schilsky, M.D., who used to be serving as period in-between CEO of CancerLinQ, will proceed his position as ASCO’s leader scientific officer.
CancerLinQ collects and analyzes records from most cancers sufferers at practices national, drawing from digital well being data, to tell and enhance the standard of most cancers care. Its database accommodates greater than one million most cancers affected person data. The trouble has two primary parts:
• The CancerLinQ high quality growth and data-sharing platform for oncology practices,
• CancerLinQ Discovery, which supplies get admission to to top quality, de-identified datasets derived from the affected person records to instructional researchers, non-profit organizations, executive companies, business, and others within the oncology neighborhood.
CancerLinQ LLC additionally has established quite a few collaborations with executive and nonprofit entities — together with American Society of Radiation Oncology, Meals and Drug Management, and the Nationwide Most cancers Institute — in addition to business via its collaborators AstraZeneca, Tempus, and Concerto HealthAI.
In a observation, ASCO CEO and CancerLinQ LLC Board of Governors Chair Clifford A. Hudis, M.D., mentioned Wiegert’s arrival “comes at a pivotal time, as we’re briefly construction on and bettering CancerLinQ’s core high quality growth platform for oncologists and knowledge analytics products and services for the wider most cancers neighborhood.”
As CEO, Wiegert shall be tasked with creating new answers to assist oncology practices enhance the day by day care they supply their sufferers and proceeding to serve CancerLinQ collaborators.